Juan Eugenio Ochoa

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper ∗

Gianfranco Parati, Grzegorz Bilo, Martino F. Pengo et al. · Journal of Hypertension · 2023 · 193 citations · Full text

Medicine, Cardiology, Physiology +17

Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension

Gianfranco Parati, George S. Stergiou, Grzegorz Bilo et al. · Journal of Hypertension · 2021 · 172 citations · Full text

Medicine, Cardiology, Cardiovascular Nursing +16

Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement

George S. Stergiou, Gianfranco Parati, Charalambos Vlachopoulos et al. · Journal of Hypertension · 2016 · 149 citations

Medicine, Cardiology, Internal Medicine +17